Special Issue "Marine Natural Products Modulating the Immune System"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (20 December 2021).
Marine organisms have been a source for bioactive compounds and several drugs that are currently in wide use. Traditional medicine throughout the globe, spanning from the Mediterranean to the Red Sea, Gulf of Bengal, South China Sea, and more, has used extracts from marine organisms as therapeutic remedies. The availability of novel analytical methods, as well as the acknowledgement that marine organisms can provide not only therapeutic but also nutritional resources, has boosted research in the field. A major use of marine organisms and marine organism extracts is the modulating of immune responses, to suppress inflammation, boost anti-tumor immune responses, or affect metabolism and therefore immune-mediated diseases. Our understanding of the contribution of the immune system in the development of diseases has grown, and the impact of marine organism-derived extracts or marine organisms themselves as nutritional supplements on these mechanisms is currently being elucidated. The aim of this Special Issue is to promote research in the field and highlight the importance of marine organisms in health as modulators of the immune system. Work describing the selective action of compounds isolated from marine organisms on the therapy of immune-related diseases or as nutritional supplements supporting health will also be included in this Special Issue.
Prof. Dr. Christos Tsatsanis
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cardiovascular disease
- marine products
- fish side streams
- T cells